AMPE Ampio Pharmaceuticals Inc

Price (delayed)

$1.71

Market cap

$316.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.07

Enterprise value

$308.08M

Sector: Healthcare
Industry: Biotechnology

Highlights

Ampio Pharmaceuticals's equity has soared by 159% YoY and by 69% from the previous quarter
The quick ratio has soared by 155% QoQ and by 44% YoY
The net income is up by 24% since the previous quarter but it has declined by 11% year-on-year

Key stats

What are the main financial stats of AMPE
Market
Shares outstanding
185.06M
Market cap
$316.44M
Enterprise value
$308.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
28.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$12.32M
EBITDA
-$11.14M
Free cash flow
-$16.66M
Per share
EPS
-$0.07
Free cash flow per share
-$0.09
Book value per share
$0.06
Revenue per share
$0
TBVPS
$0.09
Balance sheet
Total assets
$15.54M
Total liabilities
$4.82M
Debt
$999,000
Equity
$10.73M
Working capital
$8.92M
Liquidity
Debt to equity
0.09
Current ratio
5.65
Quick ratio
4.88
Net debt/EBITDA
0.75
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-97.9%
Return on equity
-192.9%
Return on invested capital
-269.3%
Return on capital employed
-90.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMPE stock price

How has the Ampio Pharmaceuticals stock price performed over time
Intraday
1.18%
1 week
-12.76%
1 month
0.59%
1 year
163.08%
YTD
7.55%
QTD
7.55%

Financial performance

How have Ampio Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.07M
Net income
-$12.3M
Gross margin
N/A
Net margin
N/A
Ampio Pharmaceuticals's operating income has decreased by 37% YoY but it has increased by 9% QoQ
The net income is up by 24% since the previous quarter but it has declined by 11% year-on-year

Growth

What is Ampio Pharmaceuticals's growth rate over time

Valuation

What is Ampio Pharmaceuticals stock price valuation
P/E
N/A
P/B
28.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 30% since the previous quarter
Ampio Pharmaceuticals's equity has soared by 159% YoY and by 69% from the previous quarter
AMPE's price to book (P/B) is 41% more than its last 4 quarters average of 20.0

Efficiency

How efficient is Ampio Pharmaceuticals business performance
Ampio Pharmaceuticals's return on invested capital has shrunk by 55% YoY but it has increased by 17% QoQ
The ROE has increased by 44% since the previous quarter and by 13% year-on-year
The return on assets has declined by 40% year-on-year but it has increased by 23% since the previous quarter

Dividends

What is AMPE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMPE.

Financial health

How did Ampio Pharmaceuticals financials performed over time
The quick ratio has soared by 155% QoQ and by 44% YoY
The current ratio has soared by 112% from the previous quarter and by 36% YoY
The company's debt is 91% lower than its equity
Ampio Pharmaceuticals's equity has soared by 159% YoY and by 69% from the previous quarter
AMPE's debt to equity has dropped by 71% year-on-year and by 47% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.